Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,793 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Collagen triple helix repeat-containing protein 1 is a novel biomarker of right ventricular involvement in pulmonary hypertension.
Yokokawa T, Nishiura K, Katahira M, Sato Y, Miura S, Sato A, Shimizu T, Misaka T, Sato T, Kaneshiro T, Oikawa M, Yoshihisa A, Sugimoto K, Fukushima K, Nakazato K, Takeishi Y. Yokokawa T, et al. Among authors: miura s. Can J Cardiol. 2024 Apr 29:S0828-282X(24)00337-4. doi: 10.1016/j.cjca.2024.04.016. Online ahead of print. Can J Cardiol. 2024. PMID: 38692430
Association between pre-treatment with statin and its inhibitory effect on the onset of coronary artery disease at the time of coronary computed tomography angiography: a new look at an old medication.
Miura-Takahashi E, Tashiro K, Shiga Y, Kawahira Y, Kato Y, Kuwano T, Sugihara M, Otsu Y, Kamimura H, Miura SI. Miura-Takahashi E, et al. Among authors: miura si. Heart Vessels. 2024 Apr 30. doi: 10.1007/s00380-024-02407-4. Online ahead of print. Heart Vessels. 2024. PMID: 38687349
Correction: Impact of renal denervation on quality of life (How does renal denervation contribute to improving hypertension treatment affected by poor medication adherence?).
Okamura K, Shimada H, Imazato K, Sako H, Udo A, Taniguchi K, Morisaki S, Imamura I, Urata H, Arima H, Miura SI. Okamura K, et al. Among authors: miura si. Hypertens Res. 2024 Apr 24. doi: 10.1038/s41440-024-01697-5. Online ahead of print. Hypertens Res. 2024. PMID: 38658650 No abstract available.
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).
Nishioka N, Imai H, Endo M, Notsu A, Doshita K, Igawa S, Yokouchi H, Ninomiya T, Tokito T, Soda S, Fujiwara T, Asao T, Nakamichi S, Kawamura T, Inomata M, Nakashima K, Ito K, Goto Y, Umeda Y, Hirai S, Ushio R, Yokoo K, Takeda T, Fukui T, Ishihara M, Osaki T, Kubo S, Fujiwara T, Yamamoto C, Tsuda T, Tamura N, Hosokawa S, Chihara Y, Ikeda S, Furuya N, Nakahara Y, Miura S, Okamoto H. Nishioka N, et al. Among authors: miura s. Target Oncol. 2024 Apr 13. doi: 10.1007/s11523-024-01048-x. Online ahead of print. Target Oncol. 2024. PMID: 38613731
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
Gibson CM, Duffy D, Korjian S, Bahit MC, Chi G, Alexander JH, Lincoff AM, Heise M, Tricoci P, Deckelbaum LI, Mears SJ, Nicolau JC, Lopes RD, Merkely B, Lewis BS, Cornel JH, Trebacz J, Parkhomenko A, Libby P, Sacks FM, Povsic TJ, Bonaca M, Goodman SG, Bhatt DL, Tendera M, Steg PG, Ridker PM, Aylward P, Kastelein JJP, Bode C, Mahaffey KW, Nicholls SJ, Pocock SJ, Mehran R, Harrington RA; AEGIS-II Committees and Investigators. Gibson CM, et al. N Engl J Med. 2024 May 2;390(17):1560-1571. doi: 10.1056/NEJMoa2400969. Epub 2024 Apr 6. N Engl J Med. 2024. PMID: 38587254 Clinical Trial.
2,793 results